Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$19.94

0.07 (0.35%)

12:45
08/15/19
08/15
12:45
08/15/19
12:45

Exelixis call volume above normal and directionally bullish

Bullish option flow detected in Exelixis with 3,267 calls trading, 1.8x expected, and implied vol increasing over 1 point to 43.05%. Sep-19 22 calls and Aug-19 20 calls are the most active options, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 0.03. Earnings are expected on October 31st.

  • 09

    Sep

EXEL Exelixis
$19.94

0.07 (0.35%)

06/17/19
STFL
06/17/19
NO CHANGE
STFL
Stifel would be surprised if another suitor tries to outbid Pfizer for Array
After Pfizer (PFE) announced an agreement to acquire Array BioPharma (ARRY) for $48 per share in cash, Stifel analyst Stephen Willey said he views the deal as a "fitting," "logical" and "appropriate" conclusion for Array shareholders and he would be "very surprised" if another suitor tried to compete with a higher priced offer. He believes a "very fair valuation" is implied by the $11.4B price Pfizer has agreed to pay, Willey added. He also sees the deal announcement providing a tailwind for the sector, specifically for small-to-mid cap oncology companies that are "perceived to have achieved some meaningful level of de-risking." As examples, he offers Exelixis (EXEL) and Blueprint Medicines (BPMC), though Willey added that a potentially shortened exclusivity runway could make a deal for Exelixis "a bit harder for a strategic to rationalize."
06/18/19
RHCO
06/18/19
DOWNGRADE
Target $48
RHCO
Hold
Array BioPharma downgraded to Hold from Buy at SunTrust
SunTrust analyst Peter Lawson downgraded Array BioPharma (ARRY) to Hold but raised his price target to $48 from $32 after the company announced that it is being acquired by Pfizer (PFE) at that price. The analyst notes that the 79% premium to the company's last closing price looks like a "fair valuation" based on his analysis of past comps and his M&A valuation model. Lawson adds that the the deal is "encouraging" within the biotech space with positive implications for other potential acquisition targets such as Agios Pharmaceuticals (AGIO) and Mirati herapeutics (MRTX) along with companies with strong chemistry such Incyte Corporation (INCY) and Exelixis (EXEL).
06/21/19
WBLR
06/21/19
NO CHANGE
WBLR
Outperform
William Blair an 'aggressive' buyer of Exelixis on weakness from clinical miss
William Blair analyst Andy Hsieh is an "aggressive" buyer of Exelixis (EXEL) shares on weakness after the company's partner Roche (RHHBY) informed the company that the Phase III IMspire170 trial, which assesses the safety and efficacy of the combination of Cotellic and Tecentriq, did not meet the primary endpoint of progression-free survival in treatment-naive melanoma. Hsieh says that while the news is disappointing, he reiterates that his bullish thesis resides in Exelixis's growth potential, driven by the Cabometyx franchise. As a result, the melanoma clinical setback does not impact the analyst's stock outlook. Further, he points out that he and the Street have not modeled revenue contribution from the IMspire170 study. Hsieh keeps an Outperform rating on Exelixis.
07/15/19
PIPR
07/15/19
NO CHANGE
PIPR
Exelixis trial updates 'encouraging,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $45 price target on Exelixis, saying he is "confident" in CABO growth with net product sales forcast of $200M in Q2, $842M for FY19, and $1.08B in FY20. The analyst's note, titled Cabometyx I-O Combo Opportunity Grows in Phase Ib COSMIC-021 Study,' comes after the company announced new protocol updates to Phase Ib COSMIC-021 trial of Cabometyx + Tecentriq, which were spurred by "encouraging early efficacy and safety data in advanced NSCLC and mCRPC cohorts."

TODAY'S FREE FLY STORIES

TACO

Del Taco

$10.90

-0.13 (-1.18%)

11:49
08/20/19
08/20
11:49
08/20/19
11:49
Periodicals
Del Taco said to hire bankers to consider sale, blog report claims »

Del Taco Restaurants has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 04

    Nov

FB

Facebook

$184.89

-1.33 (-0.71%)

11:44
08/20/19
08/20
11:44
08/20/19
11:44
Periodicals
Executive says Facebook new privacy feature may dent revenue, Bloomberg reports »

Facebook finished a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

M

Macy's

$15.70

-0.43 (-2.67%)

11:40
08/20/19
08/20
11:40
08/20/19
11:40
Options
Short-term put buyer as Macy's hits new lows »

Short-term put buyer as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MA

MasterCard

$279.09

1.05 (0.38%)

, GS

Goldman Sachs

$201.86

-0.35 (-0.17%)

11:34
08/20/19
08/20
11:34
08/20/19
11:34
Hot Stocks
Apple launches Apple Card for U.S. customers »

Apple Card, a credit card…

MA

MasterCard

$279.09

1.05 (0.38%)

GS

Goldman Sachs

$201.86

-0.35 (-0.17%)

UBER

Uber

$35.81

1.23 (3.56%)

AAPL

Apple

$212.98

2.66 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 27

    Oct

BYND

Beyond Meat

$155.67

11.23 (7.77%)

, HAIN

Hain Celestial

$19.80

-2.08 (-9.51%)

11:31
08/20/19
08/20
11:31
08/20/19
11:31
On The Fly
Beyond Meat upgrade, HP downgrade among today's top analyst actions »

Check out today's top…

BYND

Beyond Meat

$155.67

11.23 (7.77%)

HAIN

Hain Celestial

$19.80

-2.08 (-9.51%)

HPQ

HP Inc.

$19.06

-0.16 (-0.83%)

ABBV

AbbVie

$67.39

0.84 (1.26%)

PPC

Pilgrim's Pride

$30.60

1.45 (4.97%)

SQ

Square

$64.52

0.41 (0.64%)

PYPL

PayPal

$108.44

0.8 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 09

    Sep

  • 10

    Sep

  • 15

    Sep

  • 16

    Sep

  • 25

    Sep

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

HGV

Hilton Grand Vacations

$31.11

2.905 (10.30%)

, APO

Apollo Global

$34.24

0.55 (1.63%)

11:29
08/20/19
08/20
11:29
08/20/19
11:29
Recommendations
Hilton Grand Vacations, Apollo Global, Blackstone analyst commentary at Goldman Sachs »

Potential consolidation…

HGV

Hilton Grand Vacations

$31.11

2.905 (10.30%)

APO

Apollo Global

$34.24

0.55 (1.63%)

BX

Blackstone

$48.70

0.85 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AAPL

Apple

$213.03

2.71 (1.29%)

11:29
08/20/19
08/20
11:29
08/20/19
11:29
Periodicals
Apple's health team sees departures as tension brews over direction, CNBC says »

Apple's health team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLEX

Flex

$10.05

0.02 (0.20%)

11:25
08/20/19
08/20
11:25
08/20/19
11:25
Conference/Events
Flex to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

SIG

Signet Jewelers

$11.88

-0.45 (-3.65%)

11:20
08/20/19
08/20
11:20
08/20/19
11:20
Options
Put seller smacks bid for 2K Jan 10 puts in Signet Jewelers »

Put seller smacks bid for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

11:20
08/20/19
08/20
11:20
08/20/19
11:20
General news
Treasury announced $95 B in 4- and 8-week bills for Thursday »

Treasury announced $95 B…

TJX

TJX

$50.31

-1.24 (-2.41%)

11:19
08/20/19
08/20
11:19
08/20/19
11:19
Earnings
Breaking Earnings news story on TJX 

TJX sees Q4 EPS 74c-77c

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.32

-1.23 (-2.39%)

11:19
08/20/19
08/20
11:19
08/20/19
11:19
Earnings
TJX sees FY20 revenue $40.9B-$41.2B, consensus $41.33B »

Sees FY20 Marmaxx comp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.30

-1.25 (-2.42%)

11:18
08/20/19
08/20
11:18
08/20/19
11:18
Earnings
Breaking Earnings news story on TJX »

TJX sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TRMD

TORM A/S

$7.10

(0.00%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Hot Stocks
Breaking Hot Stocks news story on TORM A/S »

TORM PLC (Class A Stock)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$50.16

-1.39 (-2.70%)

11:17
08/20/19
08/20
11:17
08/20/19
11:17
Earnings
Breaking Earnings news story on TJX »

TJX sees Marshall's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.16

-1.395 (-2.71%)

11:16
08/20/19
08/20
11:16
08/20/19
11:16
Hot Stocks
TJX sees buying back approximately $1.75B of TJX stock for FY20 »

Comments taken from Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/20/19
08/20
11:16
08/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VUZI

Vuzix

$1.88

-0.08 (-4.08%)

11:15
08/20/19
08/20
11:15
08/20/19
11:15
Hot Stocks
Vuzix receives follow-on Smart Glasses order from 1Minuut Innovation »

Vuzix Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$50.15

-1.4 (-2.72%)

11:14
08/20/19
08/20
11:14
08/20/19
11:14
Hot Stocks
Breaking Hot Stocks news story on TJX »

TJX saw small impact due…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TJX

TJX

$50.15

-1.4 (-2.72%)

11:13
08/20/19
08/20
11:13
08/20/19
11:13
Hot Stocks
Breaking Hot Stocks news story on TJX »

TJX CEO says feels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

TRMD

TORM A/S

$7.10

(0.00%)

11:12
08/20/19
08/20
11:12
08/20/19
11:12
Hot Stocks
Breaking Hot Stocks news story on TORM A/S »

TORM PLC (Class A Stock)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZUO

Zuora

$13.60

-0.065 (-0.48%)

11:08
08/20/19
08/20
11:08
08/20/19
11:08
Earnings
Zuora appoints new Chief Product Officer, Chief Customer Officer »

Zuora (ZUO) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

FB

Facebook

$184.95

-1.27 (-0.68%)

11:08
08/20/19
08/20
11:08
08/20/19
11:08
Hot Stocks
Facebook announces new tool for users' data control »

Facebook announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

11:08
08/20/19
08/20
11:08
08/20/19
11:08
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.